Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
21/08/2026 07:08
BRIEF-Vicore Pharma Q2 Operating Loss At SEK 150.1 Million Aug 21 (Reuters) - Vicore Pharma Holding AB VICOR.ST:
Q2 OPERATING PROFIT SEK -150.1 MILLION
Q2 NET SALES SEK 2.2 MILLION
Source text: ID:nMFN2qQdW5
Further company coverage: VICOR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2